Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413498
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-05-09
Brief Title:
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed Refractory Multiple Myeloma
Sponsor:
Kite A Gilead Company
Organization:
Gilead Sciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-07
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-09
First Submit QC Date:
May 9 2024
Study First Post Date:
2024-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-14
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED